This content is machine translated Hypertrophic cardiomyopathies (HCM) How do myosin inhibitors perform in different HCM phenotypes? Cardiac myosin inhibitors have been developed as a targeted therapeutic option for modulating sarcomere function. While in clinical trials in obstructive hypertrophic cardiomyopathy they brought about a greater improvement in...…
View Post 5 min This content is machine translated Hypertrophic obstructive cardiomyopathy Targeted drug treatment possible Hypertrophic cardiomyopathies are characterized by a thickening of the heart muscle without accompanying dilatation. In 70% of cases, there is an obstruction of the left ventricular outflow tract, which is…
